Biotech

The Future of Gene Editing Beyond CRISPR

Emerging gene editing technologies including base editing, prime editing, ZFNs, and TALENs show promising therapeutic applications treating genetic diseases.

YolTech Sells China Rights to Cholesterol Gene Editing Therapy for $29 Million

Biotech firm YolTech has reached a significant agreement to sell the China rights to its innovative cholesterol-lowering gene editing therapy to Salubris, a leading Chinese pharmaceutical company, for $29 million.

New Funding for Smart Insulin Projects

£2.7 million will be allocated to six smart insulin projects to help fund research into the potentially revolutionary therapy area.

Merck Group’s Strategic Acquisition of Eyebio Enhances Ophthalmology Portfolio

$3 billion deal: Merck has announced the acquisition of Eyebio, a cutting-edge biotechnology company specializing in innovative treatments for eye diseases.

The 10 Biotech Industry Trends Shaping the Future

Read our run down of the cutting-edge biotech industry trends revolutionizing the life science industry.

OXGENE Seeks to Overcome Challenges in Gene Therapy Production

OXGENE, a WuXi Advanced Therapies company, hopes to pioneer a new frontier in Gene Therapy GMP manufacturing.